Tratamiento de 1L CNMP EGFR mut: necesidad de biopsia a la progresión (documento SEOM-GECP)
|
TRATAMIENTO DE 1L CNMP EGFR mut: NECESIDAD DE BIOPSIA A LA PROGRESIÓN (DOCUMENTO SEOM-GECP) |
1 |
|
Número de diapositiva 2 |
2 |
|
Molecular alterations in lung cancer |
3 |
|
EGFR population profile |
4 |
|
EGFR TKIs versus Chemotherapy |
5 |
|
Erlotinib versus Gefitinib |
6 |
|
Afatinib versus Gefitinib |
7 |
|
Scenarios of PD after TKI therapy |
8 |
|
Scenarios of PD after TKI therapy |
9 |
|
Scenarios of PD after TKI therapy |
10 |
|
Therapy Algorithm EGFR mut NSCLC |
11 |
|
Conclusions |
12 |
|
What happens in 2018? |
13 |
|
What happens in 2018? |
14 |
|
What happens in 2018? |
15 |
|
Future |
16 |
|
Gracias |
17 |